• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

透明细胞腺癌与己烯雌酚暴露女性的现状

Clear cell adenocarcinoma and the current status of DES-exposed females.

作者信息

Herbst A L

出版信息

Cancer. 1981 Jul 15;48(2 Suppl):484-8. doi: 10.1002/1097-0142(19810715)48:1+<484::aid-cncr2820481308>3.0.co;2-x.

DOI:10.1002/1097-0142(19810715)48:1+<484::aid-cncr2820481308>3.0.co;2-x
PMID:7272973
Abstract

Currently, over 400 cases of clear cell adenocarcinoma of the vagina and cervix occurring in females born after 1940 have been accessioned into the Registry for Research on Hormonal Transplacental Carcinogenesis. Cases have been identified throughout the United States as well as Australia, Canada, Mexico, and Europe. Intrauterine exposure to DES and similar nonsteroidal estrogens have been uncovered in about two-thirds of the cases with an available maternal history. A peak in the age incidence curve of the DES-related cases has been observed at about 19 years with the age range being 7-30 years. The five-year survival for 400 patients has been 80%. Numerous nonmalignant epithelial changes have been observed. It appears that there has not been an increase in the occurrence of premalignant or malignant squamous cell lesions among the DES exposed. Premature birth has been more common among DES-exposed women. For those in whom there is evidence of a midpregnancy loss or premature ripening of the cervix during pregnancy, a cerclage procedure has been effective in producing a desirable outcome.

摘要

目前,超过400例1940年后出生的女性发生的阴道和宫颈透明细胞腺癌已被纳入激素经胎盘致癌作用研究登记处。病例已在美国以及澳大利亚、加拿大、墨西哥和欧洲被确认。在约三分之二有可用母亲病史的病例中,发现了子宫内接触己烯雌酚和类似非甾体雌激素的情况。与己烯雌酚相关病例的年龄发病率曲线在约19岁时出现峰值,年龄范围为7至30岁。400名患者的五年生存率为80%。观察到许多非恶性上皮变化。似乎在接触己烯雌酚的人群中,癌前或恶性鳞状细胞病变的发生率没有增加。早产在接触己烯雌酚的女性中更为常见。对于那些在孕期有中期妊娠丢失或宫颈过早成熟证据的女性,宫颈环扎术已被证明能产生理想的结果。

相似文献

1
Clear cell adenocarcinoma and the current status of DES-exposed females.透明细胞腺癌与己烯雌酚暴露女性的现状
Cancer. 1981 Jul 15;48(2 Suppl):484-8. doi: 10.1002/1097-0142(19810715)48:1+<484::aid-cncr2820481308>3.0.co;2-x.
2
Age-incidence and risk of diethylstilbestrol-related clear cell adenocarcinoma of the vagina and cervix.己烯雌酚相关的阴道和宫颈透明细胞腺癌的年龄发病率及风险
Am J Obstet Gynecol. 1977 May 1;128(1):43-50. doi: 10.1016/0002-9378(77)90293-9.
3
Congenital diethylstilbestrol-associated vaginal/cervical adenosis (DES babies).先天性己烯雌酚相关阴道/宫颈腺病(己烯雌酚暴露胎儿)
J Ark Med Soc. 1979 May;75(12):451-2.
4
The current status of the DES-exposed population.接受药物洗脱支架治疗人群的现状。
Obstet Gynecol Annu. 1981;10:267-78.
5
Epidemiologic aspects and factors related to survival in 384 Registry cases of clear cell adenocarcinoma of the vagina and cervix.384例阴道和宫颈透明细胞腺癌登记病例的流行病学特征及生存相关因素
Am J Obstet Gynecol. 1979 Dec 1;135(7):876-86. doi: 10.1016/0002-9378(79)90814-7.
6
DES-associated clear cell adenocarcinoma of the vagina and cervix.己烯雌酚相关的阴道和宫颈透明细胞腺癌。
Obstet Gynecol Surv. 1979 Nov;34(11):844. doi: 10.1097/00006254-197911000-00024.
7
Six years' experience with screening of a diethylstilbestrol-exposed population.对己烯雌酚暴露人群进行筛查的六年经验。
Am J Obstet Gynecol. 1979 Aug 15;134(8):860-5. doi: 10.1016/0002-9378(79)90856-1.
8
The effects in the human of diethylstilbestrol (DES) use during pregnancy.孕期使用己烯雌酚(DES)对人体的影响。
Princess Takamatsu Symp. 1987;18:67-75.
9
Prenatal diethylstilbestrol (DES) exposure. Recommendations of the Diethylstilbestrol-Adenosis (DESAD) Project for the identification and management of exposed individuals.产前己烯雌酚(DES)暴露。己烯雌酚-腺病(DESAD)项目关于已暴露个体识别与管理的建议。
Clin Pediatr (Phila). 1983 Feb;22(2):139-43.
10
In utero exposure to DES. Evaluation and followup of 199 women.子宫内暴露于己烯雌酚。199名女性的评估与随访。
Obstet Gynecol. 1978 Apr;51(4):459-63. doi: 10.1097/00006250-197804000-00015.

引用本文的文献

1
Estrogen Receptor 1 (ESR1) Agonist Induces Ovarian Differentiation and Aberrant Müllerian Duct Development in the Chinese Soft-shelled Turtle, .雌激素受体1(ESR1)激动剂诱导中华鳖卵巢分化及苗勒氏管异常发育
Zool Stud. 2020 Nov 11;59:e54. doi: 10.6620/ZS.2020.59-54. eCollection 2020.
2
Very late recurrence of Diethylstilbestrol - related clear cell carcinoma of the cervix: case report.
Gynecol Oncol Res Pract. 2015 Jul 17;2:3. doi: 10.1186/s40661-015-0010-5. eCollection 2015.
3
Combined oestrogen and progesterone for preventing miscarriage.联合使用雌激素和孕激素预防流产。
Cochrane Database Syst Rev. 2013 Sep 25;2013(9):CD009278. doi: 10.1002/14651858.CD009278.pub2.
4
Effect of prenatal exposure to lead on estrogen action in the prepubertal rat uterus.孕期铅暴露对青春期前大鼠子宫雌激素作用的影响。
ISRN Obstet Gynecol. 2011;2011:329692. doi: 10.5402/2011/329692. Epub 2012 Jan 2.
5
Biobanking and public health: is a human rights approach the tie that binds?生物银行与公共卫生:人权方法是联系两者的纽带吗?
Hum Genet. 2011 Sep;130(3):451-63. doi: 10.1007/s00439-011-1061-2. Epub 2011 Jul 15.
6
Screening and management of diethylstilbestrol exposed offspring.己烯雌酚暴露后代的筛查和管理。
Can Fam Physician. 1984 Aug;30:1679-85.
7
Borderline malignant change in recurrent müllerian papilloma of the vagina.复发性阴道苗勒管乳头状瘤的交界性恶性改变
J Clin Pathol. 1998 Nov;51(11):875-7. doi: 10.1136/jcp.51.11.875.